4//SEC Filing
Crystal Adam 4
Accession 0001209191-22-010204
CIK 0001662579other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:30 PM ET
Size
8.0 KB
Accession
0001209191-22-010204
Insider Transaction Report
Form 4
Crystal Adam
Chief Medical Officer
Transactions
- Award
Performance Restricted Stock Units
2022-02-14+26,250→ 26,250 totalExp: 2025-02-28→ Common Stock (26,250 underlying) - Award
Stock Option (Right to Buy)
2022-02-14+118,000→ 118,000 totalExercise: $22.71Exp: 2032-02-13→ Common Stock (118,000 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2022.
- [F2]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining 21,750 PRSUs shall vest upon satisfaction of certain discovery and clinical milestones.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001825445
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:30 PM ET
- Size
- 8.0 KB